Skip to search formSkip to main contentSkip to account menu

NSC 284356

Known as: NSC-284356 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mitindomide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site.
The antitumor drug mitindomide (NSC 284356) was shown to inhibit the decatenation activity of human and Chinese hamster ovary… 
1987
1987
Stability indicating assay for fetindomide (NSC 373965), a potential prodrug of mitindomide (NSC 284356), employing high-performance liquid chromatography.
1986
1986
Tricyclo[4.2.2.0(2,5)]dec-9-ene-3,4,7,8-tetracarboxylic acid diimide: formulation and stability studies.
The experimental antitumor drug, tricyclo[4.2.2.0(2,5)]dec-9-ene-3,4,7,8-tetracarboxylic acid diimide, NSC 284356, was formulated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)